About AngelMed
Angel Medical Systems is an innovator in today’s cardiac medical device arena. The company has developed the AngelMed Guardian system, which is designed to detect and warn patients of acute episodes of cardiac ischemia related to the progression of coronary artery disease and thrombotic coronary occlusion caused by vulnerable plaque ruptures.
Having recently completed US and OUS clinical trials, the company is currently enrolling patients for its ALERTS Phase II US Pivotal study. Commercially available in Brazil, this leading-edge cardiac device has been developed to reduce time to treatment, minimize heart muscle damage, and improve patient outcomes. In 2010, AngelMed received CE market approval for the commercial sale of the AngelMed Guardian System in Europe.
For its groundbreaking work, AngelMed has received several honors.
 |
Apr 2011 "Best Places to Work in New Jersey" - benefiting New Jersey's economy, workforce, and businesses. |
 |
Jun 2010 "2010 Medical Design Excellence Awards (MDEA)" - recognizing the achievements of medical product companies. |
 |
Apr 2010 "Best Places to Work in New Jersey" - benefiting New Jersey's economy, workforce, and businesses. |
 |
Nov 2008 “New Jersey Company to Watch” - recognized as an up and coming company with exciting new technologies poised to make an impact on the medical community. |
